Stay updated with breaking news from Byrob Volansky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Historically, women have received far fewer rheumatology awards than men, a trend that is changing — albeit slowly.According to recent findings published in the Annals of the Rheumatic Diseases, 83.29% of awardees honored by the six major international award-granting rheumatology bodies between 1972 and 2023 were men, while only 16.7% were women.
Johnson & Johnson has settled its lawsuit with Amgen regarding the latter company’s Stelara biosimilar, clearing the way for a January 2025 release date in the United States, according to results of a federal court filing. Meanwhile, the rheumatology world awaits the debut of other ustekinumab biosimilars in the market — and what they may portend for patient care moving forward
As a seemingly ever-increasing body of data support physical activity in patients with osteoarthritis, a growing discussion is addressing the distinction between pain and harm, and how the two are experienced by those with the disease.
EULAR has removed the use of systemic glucocorticoids from its recommendations for the management of psoriatic arthritis, according to a presentation at the EULAR 2023 Congress.
MRI and PET scans are viable alternatives to ultrasound for cranial arteries in patients with suspected giant cell arteritis, according to a 2023 update of EULAR’s recommendations for imaging in large vessel vasculitis.